Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1610820 · BCTX, BCTXL, BCTXZ

BriaCell Therapeutics Corp.

Filing with the SEC SEC-reporting company West Vancouver Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Securities removed from an exchangeA Form 25-NSE filed on Feb 26, 2026 removes a class of the company’s securities from listing. It can concern shares, warrants, notes or units — check the form for the class.
  • Net loss in 2025Net loss of $26.3M for the year (2024: −$4.8M).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Net income (loss)−$26.3M−$4.8M
Total assets$33.6M$9.4M
Stockholders’ equity$30.2M$3.2M
Cash and equivalents$29.9M$5M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends July 31. Check the annual report for the exact figures and periods.

Name as filed
BriaCell Therapeutics Corp.
Formerly: Ansell Capital Corp.
CIK
0001610820
Tickers
BCTX, BCTXL, BCTXZ
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company
Status
Filing with the SEC
State of incorporation
British Columbia, Canada
Business address
West Vancouver (outside the US)
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
July 31
Last annual report
10-K for the period ended Jul 31, 2026
Last quarterly report
10-Q for the quarter ended Apr 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Oct 28, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Annual report (10-K): 10-K for the period ended Jul 31, 2026
    Form 10-K · filed Oct 28, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Apr 30, 2026
    Form 10-Q · filed Jun 9, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jan 31, 2026
    Form 10-Q · filed Mar 10, 2026 · filing
  • Delisted by the exchange (Form 25-NSE)
    Form 25-NSE · filed Feb 26, 2026 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Jan 14, 2026 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Dec 23, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Oct 31, 2025
    Form 10-Q · filed Dec 11, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Jul 31, 2025
    Form 10-K · filed Oct 16, 2025 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Jul 16, 2025 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Jul 8, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Apr 30, 2025
    Form 10-Q · filed Jun 16, 2025 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Apr 28, 2025 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Apr 28, 2025 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Apr 22, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jan 31, 2025
    Form 10-Q · filed Mar 12, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Oct 31, 2024
    Form 10-Q · filed Dec 16, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Nov 25, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Jul 31, 2024
    Form 10-K · filed Oct 29, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Aug 23, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Jul 5, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Apr 30, 2024
    Form 10-Q · filed Jun 14, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jan 31, 2024
    Form 10-Q · filed Mar 18, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Oct 31, 2023
    Form 10-Q · filed Dec 14, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Jul 31, 2023
    Form 10-K · filed Oct 25, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Apr 30, 2023
    Form 10-Q · filed Jun 14, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jan 31, 2023
    Form 10-Q · filed Mar 16, 2023 · filing